Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 Epidemics.

Kusejko, K; Tschumi, N; Chaudron, SE; Nguyen, H; Battegay, M; Bernasconi, E; Boni, J; Huber, M; Calmy, A; Cavassini, M; Egle, A; Grabmeier-Pfistershammer, K; Haas, B; Hirsch, H; Klimkait, T; Ollinger, A; Perreau, M; Ramette, A; Flury, BB; Sarcletti, M; Scherrer, A; Schmid, P; Yerly, S; Zangerle, R; Gunthard, HF; Kouyos, RD JAIDS-J ACQ IMM DEF. 2022; 90(4): e4-e12.

Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study.

Gianni, L; Huang, CS; Egle, D; Bermejo, B; Zamagni, C; Thill, M; Anton, A; Zambelli, S; Bianchini, G; Russo, S; Ciruelos, EM; Greil, R; Semiglazov, V; Colleoni, M; Kelly, C; Mariani, G; Del Mastro, L; Maffeis, I; Valagussa, P; Viale, G ANN ONCOL. 2022; 33(5): 534-543.

Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18

Minichsdorfer, C; Fuereder, T; Leutner, M; Singer, CF; Kacerovsky-Strobl, S; Egle, D; Greil, R; Balic, M; Fitzal, F; Pfeiler, G; Frantal, S; Bartsch, R; Gnant, M ESMO OPEN. 2022; 7(2):

Randomized Clinical Study of Temporary Transvenous Phrenic Nerve Stimulation in Difficult-to-Wean Patients

Dres, M; de Abreu, MG; Merdji, H; Muller-Redetzky, H; Dellweg, D; Randerath, WJ; Mortaza, S; Jung, B; Bruells, C; Moerer, O; Scharffenberg, M; Jaber, S; Besset, S; Bitter, T; Geise, A; Heine, A; Malfertheiner, MV; Kortgen, A; Benzaquen, J; Nelson, T; Uhrig, A; Moenig, O; Meziani, F; Demoule, A; Similowski, T AM J RESP CRIT CARE. 2022; 205(10): 1169-1178.

An early glimpse at azacitidine plus venetoclax for myelodysplastic syndromes

Pleyer, L; Sekeres, MA LANCET HAEMATOL. 2022; 9(10): E714-E716.

How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant Therapy.

Roeder, F; Gerum, S; Hecht, S; Huemer, F; Jäger, T; Kaufmann, R; Klieser, E; Koch, OO; Neureiter, D; Emmanuel, K; Sedlmayer, F; Greil, R; Weiss, L; Cancers (Basel). 2022; 14(22):

Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update

Rinnerthaler, G; Singer, C; Petru, E; Egle, D; Petzer, A; Pluschnig, U; Gampenrieder, SP; Pfeiler, G; Gnant, M; Grunberger, B; Krippl, P; Strasser-Weippl, K; Suppan, C; Brunner, C; Pusch, R; Sandholzer, M; Balic, M; Bartsch, R WIEN KLIN WOCHENSCHR. 2022;

The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes

Moyo, TK; Mendler, JH; Itzykson, R; Kishtagari, A; Solary, E; Seegmiller, AC; Gerds, AT; Ayers, GD; Dezern, AE; Nazha, A; Valent, P; van de Loosdrecht, AA; Onida, F; Pleyer, L; Cirici, BX; Tibes, R; Geissler, K; Komrokji, RS; Zhang, J; Germing, U; Steensma, DP; Wiseman, DH; Pfeilstoecker, M; Elena, C; Cross, NCP; Luebbert, M; Mesa, RA; Sanz, GF; Platzbecker, U; Patnaik, MM; Padron, E; Santini, V; Fenaux, P; Savona, MR; Kiladjian, JJ; Montalban-Bravo, G BMC CANCER. 2022; 22(1): 1013

Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study

Diel, IJ; Greil, R; Janssen, J; Kluike, CW; Behera, B; Abbasi, A; Seesaghur, A; Kellner, M; Jaeger, C; Bjorklof, K; Tomova, A; Haslbauer, F SUPPORT CARE CANCER. 2022;

Detecting Bacterial-Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia

Akimova, E; Gassner, FJ; Greil, R; Zaborsky, N; Geisberger, R INT J MOL SCI. 2022; 23(3): 1094